MeSH tree: D12.776.422
Patients with sickle cell disease are often hesitant to undergo transformative gene therapy—the current lengthy process requires multiple hospital visits to collect enough stem cells. Researchers from Boston Children's Hospital ...
Aug 25, 2026
0
47
A simple new method based on the results of two studies from Christofer Juhlin's research group can make it easier to identify the underlying cause of a common form of high blood pressure and help predict who will benefit ...
Aug 18, 2026
0
5
The devastating recent deaths of three toddlers in Queensland, linked to low iron levels, have understandably left many parents wondering whether their own child is getting enough iron. The good news is that life-threatening ...
Aug 14, 2026
0
7
Phase 3 clinical trial results (TRANSCEND-T2D-1) published in The Lancet report that retatrutide, an investigational once-weekly injection for diabetes management, can significantly improve blood sugar levels and lead to ...
Jul 11, 2026
0
921
UVA Health stroke researchers have identified a distinct and temporary pattern of gene behavior during cervical artery dissections, a leading cause of stroke in young people. These unusual gene changes may help explain the ...
Jun 30, 2026
0
3
A new collaborative study by Tel Aviv University and Sheba Medical Center marks a significant advance toward noninvasive blood testing, one of the most significant unmet needs in the market. The researchers have developed ...
Jun 25, 2026
0
9
A major Australian clinical trial has found that timing when you eat can be just as effective as traditional dietitian-led advice in trying to lower the risk of developing type 2 diabetes.
Jun 16, 2026
0
14
Once-weekly cagrilintide, an amylin receptor agonist, plus semaglutide is efficacious for adults with type 2 diabetes inadequately controlled with diet and exercise, receiving metformin with or without a sodium glucose cotransporter ...
Jun 12, 2026
0
9
Over the past few years, GLP-1 drugs have transformed the treatment landscape for obesity and type 2 diabetes. By mimicking a hormone that helps regulate blood sugar, slows digestion and curbs appetite, these medications ...
Oral GLP-1 medications have the potential to increase access to therapies that can help lower blood sugar and reduce bodyweight. At the American Diabetes Association's Scientific Session, Mass General Brigham physician investigator ...
Jun 8, 2026
0
33
